Bedside device aims to cut bleeding in liver transplants

NCT ID NCT06749405

Recruiting now Disease control Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether a bedside device called Quantra can help doctors decide when to give blood transfusions during liver transplant surgery. The device measures blood clotting in real time. Researchers hope it will reduce bleeding and the amount of blood products needed. The trial will enroll 56 adults undergoing liver transplantation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Quantra-guided transfusion algorithm
What this could lead to: If successful, this approach could reduce blood loss and the need for transfusions during liver transplantation, making the surgery safer.
What could go wrong: This is a small, early-phase study with only 56 participants, so results may not apply to all patients. The device may not significantly improve outcomes over standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic liver failure End Stage Liver Disease Hemorrhage thrombotic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LIVER TRANSPLANTATION

Contacts and locations

Locations

Toulouse University Hospital
RECRUITING

Toulouse, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.